Adari Cell Science

Executive Summary

Adari Cell Science is a San Diego-based biotechnology company specializing in ready-to-use cell-based assay kits for preclinical ADME (Absorption, Distribution, Metabolism, and Excretion) studies. Founded in 2018, the company operates as the exclusive North American partner for ReadyCell (Barcelona), leveraging a unique room-temperature shipping technology that enables stable, convenient delivery of cell-based assays. These kits streamline drug discovery workflows and provide a viable alternative to animal testing, addressing a key need in the pharmaceutical industry for more efficient and ethical preclinical tools. While still in the preclinical stage and privately held, the company's focused product offering positions it within the growing cell therapy and regenerative medicine market. However, limited public information on funding, valuation, or commercial traction suggests an early-stage profile with moderate near-term visibility.

Upcoming Catalysts (preview)

• TBDExpansion of product line or new partnership agreements40% success
• TBDRegulatory endorsement or adoption by major pharma20% success